Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial. (Q45917636)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2009

Language	Label	Description	Also known as
English	Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.	scientific article published in August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

1 reference

based on heuristic

inferred from title

author name string

James S Zebrack

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Mark Munger

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

John Macgregor

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

William L Lombardi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Gregory P Stoddard

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Edward M Gilbert

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

language of work or name

0 references

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

29

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

883-890

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Nitric oxide and nitrovasodilators: similarities, differences and potential interactions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.883

21 January 2018

Identifiers

10.1592/PHCO.29.8.883

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637941

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45917636&oldid=1514216107"